0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopsy Punch Tool Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-17X17288
Home | Market Reports | Health| Medical Devices & Equipment
Global Biopsy Punch Tool Market Research Report 2024
BUY CHAPTERS

Global Biopsy Punch Tool Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17X17288
Report
November 2025
Pages:177
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopsy Punch Tool Market

The global Biopsy Punch Tool market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A biopsy punch tool is a medical instrument used to obtain a sample of tissue for diagnostic purposes. It consists of a cylindrical or tubular handle with a sharp circular cutting edge at one end. Biopsy punch tools are available in various sizes, typically ranging from 1 mm to 8 mm or larger, depending on the required sample size.
From a downstream perspective, Dermatology accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biopsy Punch Tool leading manufacturers including KAI Group, Integra LifeSciences, CooperSurgical, GSK, KRUUSE, Acuderm, Accutec, Paramount Surgimed, Plasti Med, Acti-Med, etc., dominate supply; the top five capture approximately % of global revenue, with KAI Group leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biopsy Punch Tool market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biopsy Punch Tool Market Report

Report Metric Details
Report Name Biopsy Punch Tool Market
Segment by Type
  • Below 3 mm
  • 3-6 mm
  • Above 6 mm
Segment by Application
  • Dermatology
  • Cosmetic Procedures
  • Lab
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company KAI Group, Integra LifeSciences, CooperSurgical, GSK, KRUUSE, Acuderm, Accutec, Paramount Surgimed, Plasti Med, Acti-Med, Basco, Bright Shine, Sklar Instruments, Feather, Sterylab, MedGyn
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biopsy Punch Tool study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biopsy Punch Tool Market report?

Ans: The main players in the Biopsy Punch Tool Market are KAI Group, Integra LifeSciences, CooperSurgical, GSK, KRUUSE, Acuderm, Accutec, Paramount Surgimed, Plasti Med, Acti-Med, Basco, Bright Shine, Sklar Instruments, Feather, Sterylab, MedGyn

What are the Application segmentation covered in the Biopsy Punch Tool Market report?

Ans: The Applications covered in the Biopsy Punch Tool Market report are Dermatology, Cosmetic Procedures, Lab, Others

What are the Type segmentation covered in the Biopsy Punch Tool Market report?

Ans: The Types covered in the Biopsy Punch Tool Market report are Below 3 mm, 3-6 mm, Above 6 mm

1 Study Coverage
1.1 Introduction to Biopsy Punch Tool: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biopsy Punch Tool Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Below 3 mm
1.2.3 3-6 mm
1.2.4 Above 6 mm
1.3 Market Segmentation by Application
1.3.1 Global Biopsy Punch Tool Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dermatology
1.3.3 Cosmetic Procedures
1.3.4 Lab
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopsy Punch Tool Revenue Estimates and Forecasts 2020-2031
2.2 Global Biopsy Punch Tool Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biopsy Punch Tool Sales Estimates and Forecasts 2020-2031
2.4 Global Biopsy Punch Tool Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Biopsy Punch Tool Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Biopsy Punch Tool Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Below 3 mm Market Size by Manufacturers
3.5.2 3-6 mm Market Size by Manufacturers
3.5.3 Above 6 mm Market Size by Manufacturers
3.6 Global Biopsy Punch Tool Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biopsy Punch Tool Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Biopsy Punch Tool Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biopsy Punch Tool Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biopsy Punch Tool Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Biopsy Punch Tool Sales and Revenue by Type (2020-2031)
6.4 North America Biopsy Punch Tool Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biopsy Punch Tool Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Biopsy Punch Tool Sales and Revenue by Type (2020-2031)
7.4 Europe Biopsy Punch Tool Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biopsy Punch Tool Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Biopsy Punch Tool Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Biopsy Punch Tool Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Biopsy Punch Tool Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Biopsy Punch Tool Sales and Revenue by Type (2020-2031)
9.4 Central and South America Biopsy Punch Tool Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biopsy Punch Tool Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Biopsy Punch Tool Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Biopsy Punch Tool Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biopsy Punch Tool Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 KAI Group
11.1.1 KAI Group Corporation Information
11.1.2 KAI Group Business Overview
11.1.3 KAI Group Biopsy Punch Tool Product Models, Descriptions and Specifications
11.1.4 KAI Group Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 KAI Group Biopsy Punch Tool Sales by Product in 2024
11.1.6 KAI Group Biopsy Punch Tool Sales by Application in 2024
11.1.7 KAI Group Biopsy Punch Tool Sales by Geographic Area in 2024
11.1.8 KAI Group Biopsy Punch Tool SWOT Analysis
11.1.9 KAI Group Recent Developments
11.2 Integra LifeSciences
11.2.1 Integra LifeSciences Corporation Information
11.2.2 Integra LifeSciences Business Overview
11.2.3 Integra LifeSciences Biopsy Punch Tool Product Models, Descriptions and Specifications
11.2.4 Integra LifeSciences Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Integra LifeSciences Biopsy Punch Tool Sales by Product in 2024
11.2.6 Integra LifeSciences Biopsy Punch Tool Sales by Application in 2024
11.2.7 Integra LifeSciences Biopsy Punch Tool Sales by Geographic Area in 2024
11.2.8 Integra LifeSciences Biopsy Punch Tool SWOT Analysis
11.2.9 Integra LifeSciences Recent Developments
11.3 CooperSurgical
11.3.1 CooperSurgical Corporation Information
11.3.2 CooperSurgical Business Overview
11.3.3 CooperSurgical Biopsy Punch Tool Product Models, Descriptions and Specifications
11.3.4 CooperSurgical Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 CooperSurgical Biopsy Punch Tool Sales by Product in 2024
11.3.6 CooperSurgical Biopsy Punch Tool Sales by Application in 2024
11.3.7 CooperSurgical Biopsy Punch Tool Sales by Geographic Area in 2024
11.3.8 CooperSurgical Biopsy Punch Tool SWOT Analysis
11.3.9 CooperSurgical Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Business Overview
11.4.3 GSK Biopsy Punch Tool Product Models, Descriptions and Specifications
11.4.4 GSK Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 GSK Biopsy Punch Tool Sales by Product in 2024
11.4.6 GSK Biopsy Punch Tool Sales by Application in 2024
11.4.7 GSK Biopsy Punch Tool Sales by Geographic Area in 2024
11.4.8 GSK Biopsy Punch Tool SWOT Analysis
11.4.9 GSK Recent Developments
11.5 KRUUSE
11.5.1 KRUUSE Corporation Information
11.5.2 KRUUSE Business Overview
11.5.3 KRUUSE Biopsy Punch Tool Product Models, Descriptions and Specifications
11.5.4 KRUUSE Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 KRUUSE Biopsy Punch Tool Sales by Product in 2024
11.5.6 KRUUSE Biopsy Punch Tool Sales by Application in 2024
11.5.7 KRUUSE Biopsy Punch Tool Sales by Geographic Area in 2024
11.5.8 KRUUSE Biopsy Punch Tool SWOT Analysis
11.5.9 KRUUSE Recent Developments
11.6 Acuderm
11.6.1 Acuderm Corporation Information
11.6.2 Acuderm Business Overview
11.6.3 Acuderm Biopsy Punch Tool Product Models, Descriptions and Specifications
11.6.4 Acuderm Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Acuderm Recent Developments
11.7 Accutec
11.7.1 Accutec Corporation Information
11.7.2 Accutec Business Overview
11.7.3 Accutec Biopsy Punch Tool Product Models, Descriptions and Specifications
11.7.4 Accutec Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Accutec Recent Developments
11.8 Paramount Surgimed
11.8.1 Paramount Surgimed Corporation Information
11.8.2 Paramount Surgimed Business Overview
11.8.3 Paramount Surgimed Biopsy Punch Tool Product Models, Descriptions and Specifications
11.8.4 Paramount Surgimed Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Paramount Surgimed Recent Developments
11.9 Plasti Med
11.9.1 Plasti Med Corporation Information
11.9.2 Plasti Med Business Overview
11.9.3 Plasti Med Biopsy Punch Tool Product Models, Descriptions and Specifications
11.9.4 Plasti Med Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Plasti Med Recent Developments
11.10 Acti-Med
11.10.1 Acti-Med Corporation Information
11.10.2 Acti-Med Business Overview
11.10.3 Acti-Med Biopsy Punch Tool Product Models, Descriptions and Specifications
11.10.4 Acti-Med Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Acti-Med Recent Developments
11.11 Basco
11.11.1 Basco Corporation Information
11.11.2 Basco Business Overview
11.11.3 Basco Biopsy Punch Tool Product Models, Descriptions and Specifications
11.11.4 Basco Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Basco Recent Developments
11.12 Bright Shine
11.12.1 Bright Shine Corporation Information
11.12.2 Bright Shine Business Overview
11.12.3 Bright Shine Biopsy Punch Tool Product Models, Descriptions and Specifications
11.12.4 Bright Shine Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Bright Shine Recent Developments
11.13 Sklar Instruments
11.13.1 Sklar Instruments Corporation Information
11.13.2 Sklar Instruments Business Overview
11.13.3 Sklar Instruments Biopsy Punch Tool Product Models, Descriptions and Specifications
11.13.4 Sklar Instruments Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Sklar Instruments Recent Developments
11.14 Feather
11.14.1 Feather Corporation Information
11.14.2 Feather Business Overview
11.14.3 Feather Biopsy Punch Tool Product Models, Descriptions and Specifications
11.14.4 Feather Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Feather Recent Developments
11.15 Sterylab
11.15.1 Sterylab Corporation Information
11.15.2 Sterylab Business Overview
11.15.3 Sterylab Biopsy Punch Tool Product Models, Descriptions and Specifications
11.15.4 Sterylab Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Sterylab Recent Developments
11.16 MedGyn
11.16.1 MedGyn Corporation Information
11.16.2 MedGyn Business Overview
11.16.3 MedGyn Biopsy Punch Tool Product Models, Descriptions and Specifications
11.16.4 MedGyn Biopsy Punch Tool Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 MedGyn Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Biopsy Punch Tool Industry Chain
12.2 Biopsy Punch Tool Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Biopsy Punch Tool Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Biopsy Punch Tool Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biopsy Punch Tool Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biopsy Punch Tool Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Biopsy Punch Tool Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biopsy Punch Tool Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biopsy Punch Tool Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biopsy Punch Tool Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biopsy Punch Tool Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Biopsy Punch Tool Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Biopsy Punch Tool Sales by Region (2020-2025) & (K Units)
 Table 8. Global Biopsy Punch Tool Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Biopsy Punch Tool Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Biopsy Punch Tool Sales Share by Manufacturers (2020-2025)
 Table 12. Global Biopsy Punch Tool Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Biopsy Punch Tool Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Biopsy Punch Tool by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopsy Punch Tool as of 2024)
 Table 16. Global Biopsy Punch Tool Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Biopsy Punch Tool Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Biopsy Punch Tool Manufacturing Base and Headquarters
 Table 19. Global Biopsy Punch Tool Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Biopsy Punch Tool Sales by Type (2020-2025) & (K Units)
 Table 23. Global Biopsy Punch Tool Sales by Type (2026-2031) & (K Units)
 Table 24. Global Biopsy Punch Tool Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Biopsy Punch Tool Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Biopsy Punch Tool ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Biopsy Punch Tool Sales by Application (2020-2025) & (K Units)
 Table 29. Global Biopsy Punch Tool Sales by Application (2026-2031) & (K Units)
 Table 30. Biopsy Punch Tool High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Biopsy Punch Tool Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Biopsy Punch Tool Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Biopsy Punch Tool ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Biopsy Punch Tool Growth Accelerators and Market Barriers
 Table 37. North America Biopsy Punch Tool Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Biopsy Punch Tool Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Biopsy Punch Tool Growth Accelerators and Market Barriers
 Table 40. Europe Biopsy Punch Tool Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Biopsy Punch Tool Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Biopsy Punch Tool Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Biopsy Punch Tool Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Biopsy Punch Tool Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Biopsy Punch Tool Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Biopsy Punch Tool Investment Opportunities and Key Challenges
 Table 47. Central and South America Biopsy Punch Tool Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Biopsy Punch Tool Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Biopsy Punch Tool Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. KAI Group Corporation Information
 Table 51. KAI Group Description and Major Businesses
 Table 52. KAI Group Product Models, Descriptions and Specifications
 Table 53. KAI Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. KAI Group Sales Value Proportion by Product in 2024
 Table 55. KAI Group Sales Value Proportion by Application in 2024
 Table 56. KAI Group Sales Value Proportion by Geographic Area in 2024
 Table 57. KAI Group Biopsy Punch Tool SWOT Analysis
 Table 58. KAI Group Recent Developments
 Table 59. Integra LifeSciences Corporation Information
 Table 60. Integra LifeSciences Description and Major Businesses
 Table 61. Integra LifeSciences Product Models, Descriptions and Specifications
 Table 62. Integra LifeSciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Integra LifeSciences Sales Value Proportion by Product in 2024
 Table 64. Integra LifeSciences Sales Value Proportion by Application in 2024
 Table 65. Integra LifeSciences Sales Value Proportion by Geographic Area in 2024
 Table 66. Integra LifeSciences Biopsy Punch Tool SWOT Analysis
 Table 67. Integra LifeSciences Recent Developments
 Table 68. CooperSurgical Corporation Information
 Table 69. CooperSurgical Description and Major Businesses
 Table 70. CooperSurgical Product Models, Descriptions and Specifications
 Table 71. CooperSurgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. CooperSurgical Sales Value Proportion by Product in 2024
 Table 73. CooperSurgical Sales Value Proportion by Application in 2024
 Table 74. CooperSurgical Sales Value Proportion by Geographic Area in 2024
 Table 75. CooperSurgical Biopsy Punch Tool SWOT Analysis
 Table 76. CooperSurgical Recent Developments
 Table 77. GSK Corporation Information
 Table 78. GSK Description and Major Businesses
 Table 79. GSK Product Models, Descriptions and Specifications
 Table 80. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. GSK Sales Value Proportion by Product in 2024
 Table 82. GSK Sales Value Proportion by Application in 2024
 Table 83. GSK Sales Value Proportion by Geographic Area in 2024
 Table 84. GSK Biopsy Punch Tool SWOT Analysis
 Table 85. GSK Recent Developments
 Table 86. KRUUSE Corporation Information
 Table 87. KRUUSE Description and Major Businesses
 Table 88. KRUUSE Product Models, Descriptions and Specifications
 Table 89. KRUUSE Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. KRUUSE Sales Value Proportion by Product in 2024
 Table 91. KRUUSE Sales Value Proportion by Application in 2024
 Table 92. KRUUSE Sales Value Proportion by Geographic Area in 2024
 Table 93. KRUUSE Biopsy Punch Tool SWOT Analysis
 Table 94. KRUUSE Recent Developments
 Table 95. Acuderm Corporation Information
 Table 96. Acuderm Description and Major Businesses
 Table 97. Acuderm Product Models, Descriptions and Specifications
 Table 98. Acuderm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Acuderm Recent Developments
 Table 100. Accutec Corporation Information
 Table 101. Accutec Description and Major Businesses
 Table 102. Accutec Product Models, Descriptions and Specifications
 Table 103. Accutec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Accutec Recent Developments
 Table 105. Paramount Surgimed Corporation Information
 Table 106. Paramount Surgimed Description and Major Businesses
 Table 107. Paramount Surgimed Product Models, Descriptions and Specifications
 Table 108. Paramount Surgimed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Paramount Surgimed Recent Developments
 Table 110. Plasti Med Corporation Information
 Table 111. Plasti Med Description and Major Businesses
 Table 112. Plasti Med Product Models, Descriptions and Specifications
 Table 113. Plasti Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Plasti Med Recent Developments
 Table 115. Acti-Med Corporation Information
 Table 116. Acti-Med Description and Major Businesses
 Table 117. Acti-Med Product Models, Descriptions and Specifications
 Table 118. Acti-Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Acti-Med Recent Developments
 Table 120. Basco Corporation Information
 Table 121. Basco Description and Major Businesses
 Table 122. Basco Product Models, Descriptions and Specifications
 Table 123. Basco Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Basco Recent Developments
 Table 125. Bright Shine Corporation Information
 Table 126. Bright Shine Description and Major Businesses
 Table 127. Bright Shine Product Models, Descriptions and Specifications
 Table 128. Bright Shine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Bright Shine Recent Developments
 Table 130. Sklar Instruments Corporation Information
 Table 131. Sklar Instruments Description and Major Businesses
 Table 132. Sklar Instruments Product Models, Descriptions and Specifications
 Table 133. Sklar Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Sklar Instruments Recent Developments
 Table 135. Feather Corporation Information
 Table 136. Feather Description and Major Businesses
 Table 137. Feather Product Models, Descriptions and Specifications
 Table 138. Feather Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Feather Recent Developments
 Table 140. Sterylab Corporation Information
 Table 141. Sterylab Description and Major Businesses
 Table 142. Sterylab Product Models, Descriptions and Specifications
 Table 143. Sterylab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Sterylab Recent Developments
 Table 145. MedGyn Corporation Information
 Table 146. MedGyn Description and Major Businesses
 Table 147. MedGyn Product Models, Descriptions and Specifications
 Table 148. MedGyn Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. MedGyn Recent Developments
 Table 150. Key Raw Materials Distribution
 Table 151. Raw Materials Key Suppliers
 Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 153. Milestones in Production Technology Evolution
 Table 154. Distributors List
 Table 155. Market Trends and Market Evolution
 Table 156. Market Drivers and Opportunities
 Table 157. Market Challenges, Risks, and Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biopsy Punch Tool Product Picture
 Figure 2. Global Biopsy Punch Tool Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Below 3 mm Product Picture
 Figure 4. 3-6 mm Product Picture
 Figure 5. Above 6 mm Product Picture
 Figure 6. Global Biopsy Punch Tool Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Dermatology
 Figure 8. Cosmetic Procedures
 Figure 9. Lab
 Figure 10. Others
 Figure 11. Biopsy Punch Tool Report Years Considered
 Figure 12. Global Biopsy Punch Tool Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Biopsy Punch Tool Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Biopsy Punch Tool Revenue Market Share by Region (2020-2031)
 Figure 16. Global Biopsy Punch Tool Sales (2020-2031) & (K Units)
 Figure 17. Global Biopsy Punch Tool Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Biopsy Punch Tool Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Biopsy Punch Tool Sales Volume Market Share in 2024
 Figure 20. Global Biopsy Punch Tool Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Below 3 mm Revenue Market Share by Manufacturer in 2024
 Figure 23. 3-6 mm Revenue Market Share by Manufacturer in 2024
 Figure 24. Above 6 mm Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Biopsy Punch Tool Sales Market Share by Type (2020-2031)
 Figure 26. Global Biopsy Punch Tool Revenue Market Share by Type (2020-2031)
 Figure 27. Global Biopsy Punch Tool Sales Market Share by Application (2020-2031)
 Figure 28. Global Biopsy Punch Tool Revenue Market Share by Application (2020-2031)
 Figure 29. North America Biopsy Punch Tool Sales YoY (2020-2031) & (K Units)
 Figure 30. North America Biopsy Punch Tool Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Biopsy Punch Tool Sales Revenue (US$ Million) in 2024
 Figure 32. North America Biopsy Punch Tool Sales Volume (K Units) by Type (2020- 2031)
 Figure 33. North America Biopsy Punch Tool Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Biopsy Punch Tool Sales Volume (K Units) by Application (2020-2031)
 Figure 35. North America Biopsy Punch Tool Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Biopsy Punch Tool Sales YoY (2020-2031) & (K Units)
 Figure 40. Europe Biopsy Punch Tool Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Biopsy Punch Tool Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Biopsy Punch Tool Sales Volume (K Units) by Type (2020-2031)
 Figure 43. Europe Biopsy Punch Tool Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Biopsy Punch Tool Sales Volume (K Units) by Application (2020-2031)
 Figure 45. Europe Biopsy Punch Tool Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 47. France Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Biopsy Punch Tool Sales YoY (2020-2031) & (K Units)
 Figure 52. Asia-Pacific Biopsy Punch Tool Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Biopsy Punch Tool Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Biopsy Punch Tool Sales Volume (K Units) by Type (2020- 2031)
 Figure 55. Asia-Pacific Biopsy Punch Tool Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Biopsy Punch Tool Sales Volume (K Units) by Application (2020-2031)
 Figure 57. Asia-Pacific Biopsy Punch Tool Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 62. India Biopsy Punch Tool Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Biopsy Punch Tool Sales YoY (2020-2031) & (K Units)
 Figure 64. Central and South America Biopsy Punch Tool Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Biopsy Punch Tool Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Biopsy Punch Tool Sales Volume (K Units) by Type (2021-2031)
 Figure 67. Central and South America Biopsy Punch Tool Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Biopsy Punch Tool Sales Volume (K Units) by Application (2020-2031)
 Figure 69. Central and South America Biopsy Punch Tool Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Biopsy Punch Tool Sales YoY (2020-2031) & (K Units)
 Figure 73. Middle East and Africa Biopsy Punch Tool Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Biopsy Punch Tool Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Biopsy Punch Tool Sales Volume (K Units) by Type (2021-2031)
 Figure 76. South America Biopsy Punch Tool Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Biopsy Punch Tool Sales Volume (K Units) by Application (2020-2031)
 Figure 78. Middle East and Africa Biopsy Punch Tool Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Biopsy Punch Tool Revenue (2020-2025) & (US$ Million)
 Figure 83. Biopsy Punch Tool Industry Chain Mapping
 Figure 84. Regional Biopsy Punch Tool Manufacturing Base Distribution (%)
 Figure 85. Global Biopsy Punch Tool Production Market Share by Region (2020-2031)
 Figure 86. Biopsy Punch Tool Production Process
 Figure 87. Regional Biopsy Punch Tool Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure